COVID-19 a bigger threat to seniors than pneumonia, real-world study finds
By
Alicia Lasek
Feb 09, 2023
COVID-19 is much more deadly than bacterial or viral pneumonia, causing double the mortality rate in older, hospitalized adults, investigators say.
Deadly Legionnaires’ outbreak at nursing home puts disease back in spotlight
By
Joe Bush
Sep 16, 2022
Four deaths this summer at a Manhattan nursing home have put Legionnaire’s disease in the spotlight again.
Time from infection to COVID symptoms shortens with each new variant, study finds
By
Alicia Lasek
Aug 24, 2022
The average incubation period of SARS-CoV-2 has gradually shortened, from 5 days to 3.4. Determining incubation periods can help to pinpoint effective patient isolation periods, investigators say.
Fourth dose of Pfizer vaccine renews protection against omicron in seniors, investigators find
By
Alicia Lasek
Apr 15, 2022
A fourth dose of Pfizer’s COVID-19 vaccine cuts the risk of infection and severe illness in older adults when compared to a third dose given months earlier, a new study from Israel finds.
ACC: Infected CV implantable electronic devices often not removed
Apr 11, 2022
Although extraction within six days is linked to lower mortality, hardware not removed in 78.9 percent of patients with infected devices
Lasting cognitive decline common in older COVID-19 patients: study
By
Alicia Lasek
Mar 14, 2022
One year after hospital discharge, 9% of study participants who survived severe disease had dementia and 26% had mild cognitive impairment — a higher proportion than their uninfected peers, investigators...
Best bet against omicron? Prior infection or a booster shot, early research suggests
By
Alicia Lasek
Dec 09, 2021
A two-dose course of the Pfizer-BioNTech COVID-19 vaccine may not be enough to effectively combat the new omicron coronavirus variant, but a booster shot may do the trick, two early lab studies suggest....
Remdesivir spurs faster COVID recovery; does not affect mortality, large new study finds
By
Alicia Lasek
Mar 29, 2021
The inclusion of patients from underrepresented minority groups provides much-needed evidence about the effectiveness of remdesivir in these groups, the authors say.
Clinical Briefs for Tuesday, April 21
By
Alicia Lasek
Apr 20, 2020
Brain training can boost daily function in seniors with range of cognitive abilities … Increase in infections may indicate future cancer diagnosis …Antiviral remdesivir prevents disease progression...
Malaria drugs approved for COVID-19 use: Geriatrician warns of side effects in elderly
By
Alicia Lasek
Mar 30, 2020
Clinicians should tread carefully when treating elderly patients with two drugs newly cleared for COVID-19 patients, says a top industry doctor.